Mounjaro maker signs $2.7 billion deal on AI drug research
Major pharmaceutical partnership invests $2.7B to deploy AI engines for accelerating drug discovery and development.
The Economic TimesEnterprise AI Adoption
Weekly AI Briefing
25 signals across 1 days
Major pharmaceutical partnership invests $2.7B to deploy AI engines for accelerating drug discovery and development.
Large manufacturers adopt AI three times more than smaller firms to address productivity and workforce challenges.
Palantir scores three major enterprise AI wins with implications for data mining and analytics market expansion.